Tranexamic Acid Market Research Report Information by Formulation Type (Oral, Injectable, Topical), by Application (Menorrhagia, Surgical Bleeding Control, Trauma and Injury, Hereditary Angioedema (HAE), Postpartum Hemorrhage, Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others and Region (North America, Europe, Asia-Pacific and Rest of the World) - Forecast till 2035

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.2 MARKET ATTRACTIVENESS ANALYSIS

1.3 GLOBAL TRANEXAMIC ACID MARKET, BY FORMULATION TYPE

1.4 GLOBAL TRANEXAMIC ACID MARKET, BY APPLICATION

1.5 GLOBAL TRANEXAMIC ACID MARKET, BY END USER

1.6 GLOBAL TRANEXAMIC ACID MARKET, BY REGION

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 Data Mining Process

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 Secondary Research Data Flow:

3.5 PRIMARY RESEARCH:

3.5.1 Primary Research Data Flow:

3.5.2 Primary Research: Number of Interviews conducted

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 Revenue Analysis Approach

3.7 DATA FORECASTING

3.7.1 Data forecasting Type

3.8 DATA MODELING

3.8.1 Microeconomic Factor Analysis:

3.8.2 Data modeling:

3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 GROWTH PARAMETERS MAPPED – DRIVERS

4.2.1 Increasing Surgical Procedures

4.2.2 Growing Prevalence of Trauma Cases

4.2.3 Growing Prevalence of Heavy Menstrual Bleeding (HMB)

4.3 WHAT ARE THE CHALLENGES FACED BY INDUSTRY PARTICIPANTS?

4.3.1 Stringent Regulatory Requirements

4.3.2 High R&D Costs for New Formulations

4.4 MARKET OPPORTUNITIES MAPPED

4.4.1 Rising Demand for Minimally Invasive & Non-Surgical Treatment Options

4.4.2 Untapped Potential in Emerging Markets

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 COVID-19 IMPACT ANALYSIS

5.2.1 Impact on R & D

5.2.2 Impact on Supply Chain

5.2.3 Impact on Pricing

6 GLOBAL TRANEXAMIC ACID MARKET, BY FORMULATION TYPE

6.1 INTRODUCTION

6.2 ORAL

6.3 INJECTABLE

6.4 TROPICAL

7 GLOBAL TRANEXAMIC ACID MARKET, BY APPLICATION

7.1 INTRODUCTION

7.2 MENORRHAGIA

7.3 SURGICAL BLEEDING CONTROL

7.4 TRAUMA AND INJURY

7.5 HEREDITARY ANGIOEDEMA (HAE)

7.6 POSTPARTUM HEMORRHAGE

7.7 OTHERS

8 GLOBAL TRANEXAMIC ACID MARKET, BY END USER

8.1 INTRODUCTION

8.2 HOSPITALS & CLINICS

8.3 AMBULATORY SURGICAL CENTERS

8.4 OTHERS

9 GLOBAL TRANEXAMIC ACID MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION

10.2 MARKET SHARE ANALYSIS, 2024

10.3 COMPETITION DASHBOARD

10.3.1 PRODUCT PORTFOLIO

10.3.2 REGIONAL PRESENCE

10.3.3 STRATEGIC ALLIANCES

10.3.4 INDUSTRY EXPERIENCES

10.4 WHO ARE THE MAJOR DISRUPTORS & INNOVATORS

10.5 WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 Merger and Acquisition

10.6.2 Product launch

11 COMPANY PROFILES

11.1 PFIZER INC

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 Key Strategy

11.2 FRESENIUS KABI USA, LLC

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 Key Strategy

11.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 Key Strategy

11.4 MAXWELLIA LTD.

11.4.1 COMPANY OVERVIEW

11.4.2 PRODUCTS OFFERED

11.4.3 KEY DEVELOPMENTS

11.4.4 SWOT ANALYSIS

11.4.5 Key Strategy

11.5 AUROBINDO PHARMA USA

11.5.1 COMPANY OVERVIEW

11.5.2 PRODUCTS OFFERED

11.5.3 KEY DEVELOPMENTS

11.5.4 SWOT ANALYSIS

11.5.5 Key Strategy

11.6 SUN PHARMACEUTICAL INDUSTRIES LTD.

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 Key Strategy

11.7 APOTEX INC.

11.7.1 COMPANY OVERVIEW

11.7.2 PRODUCTS OFFERED

11.7.3 KEY DEVELOPMENTS

11.7.4 SWOT ANALYSIS

11.7.5 Key Strategy

11.8 FERRING PHARMACEUTICALS

11.8.1 COMPANY OVERVIEW

11.8.2 PRODUCTS OFFERED

11.8.3 KEY DEVELOPMENTS

11.8.4 SWOT ANALYSIS

11.8.5 Key Strategy

11.9 NORDIC PHARMA, INC

11.9.1 COMPANY OVERVIEW

11.9.2 PRODUCTS OFFERED

11.9.3 KEY DEVELOPMENTS

11.9.4 SWOT ANALYSIS

11.9.5 Key Strategy

11.10 EXELA PHARMA SCIENCES LLC

11.10.1 COMPANY OVERVIEW

11.10.2 PRODUCTS OFFERED

11.10.3 KEY DEVELOPMENTS

11.10.4 SWOT ANALYSIS

11.10.5 Key Strategy

12 DATA CITATIONS
LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 GLOBAL TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 3 GLOBAL TRANEXAMIC ACID MARKET, FOR ORAL, BY REGION, 2019–2035 (USD BILLION)

TABLE 4 GLOBAL TRANEXAMIC ACID MARKET, FOR INJECTABLE, BY REGION, 2019–2035 (USD BILLION)

TABLE 5 GLOBAL TRANEXAMIC ACID MARKET, FOR TROPICAL, BY REGION, 2019–2035 (USD BILLION)

TABLE 6 GLOBAL TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 7 GLOBAL TRANEXAMIC ACID MARKET, FOR MENORRHAGIA, BY REGION, 2019–2035 (USD BILLION)

TABLE 8 GLOBAL TRANEXAMIC ACID MARKET, FOR SURGICAL BLEEDING CONTROL, BY REGION, 2019–2035 (USD BILLION)

TABLE 9 GLOBAL TRANEXAMIC ACID MARKET, FOR TRAUMA AND INJURY, BY REGION, 2019–2035 (USD BILLION)

TABLE 10 GLOBAL TRANEXAMIC ACID MARKET, FOR HEREDITARY ANGIOEDEMA (HAE), BY REGION, 2019–2035 (USD BILLION)

TABLE 11 GLOBAL TRANEXAMIC ACID MARKET, FOR POSTPARTUM HEMORRHAGE, BY REGION, 2019–2035 (USD BILLION)

TABLE 12 GLOBAL TRANEXAMIC ACID MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION)

TABLE 13 GLOBAL TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 14 GLOBAL TRANEXAMIC ACID MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2035 (USD BILLION)

TABLE 15 GLOBAL TRANEXAMIC ACID MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2035 (USD BILLION)

TABLE 16 GLOBAL TRANEXAMIC ACID MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION)

TABLE 17 GLOBAL TRANEXAMIC ACID MARKET, BY REGION, 2019-2035 (USD BILLION)

TABLE 18 NORTH AMERICA TRANEXAMIC ACIDS MARKET, BY COUNTRY, 2019–2035 (USD BILLION)

TABLE 19 NORTH AMERICA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 20 NORTH AMERICA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 21 NORTH AMERICA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 22 US: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 23 US: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 24 US: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 25 CANADA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 26 CANADA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 27 CANADA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 28 EUROPE: TRANEXAMIC ACIDS MARKET, BY COUNTRY, 2019–2035 (USD BILLION)

TABLE 29 EUROPE: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 30 EUROPE: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 31 EUROPE: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 32 GERMANY: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 33 GERMANY: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 34 GERMANY: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 35 UK: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 36 UK: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 37 UK: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 38 FRANCE: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 39 FRANCE: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 40 FRANCE: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 41 ITALY: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 42 ITALY: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 43 ITALY: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 44 SPAIN: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 45 SPAIN: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 46 SPAIN: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 47 REST OF EUROPE: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 48 REST OF EUROPE: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 49 REST OF EUROPE: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 50 ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY COUNTRY, 2019–2035 (USD BILLION)

TABLE 51 ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 52 ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 53 ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 54 CHINA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 55 CHINA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 56 CHINA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 57 INDIA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 58 INDIA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 59 INDIA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 60 JAPAN: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 61 JAPAN: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 62 JAPAN: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 63 SOUTH KOREA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 64 SOUTH KOREA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 65 SOUTH KOREA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 66 AUSTRALIA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 67 AUSTRALIA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 68 AUSTRALIA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 69 REST OF ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 70 REST OF ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 71 REST OF ASIA-PACIFIC: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 72 REST OF THE WORLD: TRANEXAMIC ACID MARKET, BY COUNTRY, 2019–2035 (USD BILLION)

TABLE 73 REST OF THE WORLD: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 74 REST OF THE WORLD: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 75 REST OF THE WORLD: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 76 MIDDLE EAST: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 77 MIDDLE EAST: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 78 MIDDLE EAST: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 79 AFRICA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 80 AFRICA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 81 AFRICA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 82 LATIN AMERICA: TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2019–2035 (USD BILLION)

TABLE 83 LATIN AMERICA: TRANEXAMIC ACID MARKET, BY APPLICATION, 2019–2035 (USD BILLION)

TABLE 84 LATIN AMERICA: TRANEXAMIC ACID MARKET, BY END USER, 2019–2035 (USD BILLION)

TABLE 85 MERGER AND ACQUISITION

TABLE 86 PRODUCT LAUNCH

TABLE 87 PFIZER INC: PRODUCTS OFFERED

TABLE 88 FRESENIUS KABI USA, LLC: PRODUCTS OFFERED

TABLE 89 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS OFFERED

TABLE 90 MAXWELLIA LTD.: PRODUCTS OFFERED

TABLE 91 AUROBINDO PHARMA USA: PRODUCTS OFFERED

TABLE 92 SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED

TABLE 93 APOTEX INC.: PRODUCTS OFFERED

TABLE 94 FERRING PHARMACEUTICALS: PRODUCTS OFFERED

TABLE 95 NORDIC PHARMA, INC: PRODUCTS OFFERED

TABLE 96 EXELA PHARMA SCIENCES LLC: PRODUCTS OFFERED
LIST OF FIGURES

FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL TRANEXAMIC ACID MARKET, 2024

FIGURE 2 GLOBAL TRANEXAMIC ACID MARKET ANALYSIS, BY FORMULATION TYPE, 2024

FIGURE 3 GLOBAL TRANEXAMIC ACID ANALYSIS, BY APPLICATION, 2024

FIGURE 4 GLOBAL TRANEXAMIC ACID ANALYSIS, BY END USER, 2024

FIGURE 5 GLOBAL TRANEXAMIC ACID MARKET ANALYSIS, BY REGION, 2024

FIGURE 1 GLOBAL TRANEXAMIC ACID MARKET: STRUCTURE

FIGURE 2 GLOBAL TRANEXAMIC ACID MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)

FIGURE 3 DRIVER IMPACT ANALYSIS (2019-2035)

FIGURE 4 PORTER’S FIVE FORCES MODEL: GLOBAL TRANEXAMIC ACID MARKET

FIGURE 5 GLOBAL TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, SEGMENT ATTRACTIVENESS ANALYSIS

FIGURE 6 GLOBAL TRANEXAMIC ACID MARKET, BY FORMULATION TYPE, 2024 & 2035 (USD BILLION)

FIGURE 7 GLOBAL TRANEXAMIC ACID MARKET SHARE (%), BY FORMULATION TYPE, 2024

FIGURE 8 GLOBAL TRANEXAMIC ACID MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS

FIGURE 9 GLOBAL TRANEXAMIC ACID MARKET, BY APPLICATION, 2024 & 2035 (USD BILLION)

FIGURE 10 GLOBAL TRANEXAMIC ACID MARKET SHARE (%), BY APPLICATION, 2024

FIGURE 11 GLOBAL TRANEXAMIC ACID MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS

FIGURE 12 GLOBAL TRANEXAMIC ACID MARKET, BY END USER, 2024 & 2035 (USD BILLION)

FIGURE 13 GLOBAL TRANEXAMIC ACID MARKET SHARE (%), BY END USER, 2024

FIGURE 14 GLOBAL TRANEXAMIC ACID MARKET, BY REGION, 2024 & 2035 (USD BILLION)

FIGURE 15 GLOBAL TRANEXAMIC ACID MARKET SHARE (%), BY REGION, 2024

FIGURE 16 NORTH AMERICA: TRANEXAMIC ACID MARKET, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 17 NORTH AMERICA: TRANEXAMIC ACID MARKET SHARE (%), BY COUNTRY, 2024

FIGURE 18 EUROPE: TRANEXAMIC ACIDS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 19 EUROPE: TRANEXAMIC ACIDS MARKET SHARE, BY COUNTRY, 2024 (%)

FIGURE 20 ASIA-PACIFIC: TRANEXAMIC ACID MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 21 ASIA-PACIFIC: TRANEXAMIC ACID MARKET SHARE, BY COUNTRY, 2024 (%)

FIGURE 22 REST OF THE WORLD: TRANEXAMIC ACID MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD BILLION)

FIGURE 23 REST OF THE WORLD: TRANEXAMIC ACID MARKET SHARE, BY REGION, 2024 (%)

FIGURE 24 GLOBAL TRANEXAMIC ACID MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024

FIGURE 25 COMPETITOR DASHBOARD: GLOBAL TRANEXAMIC ACID MARKET

FIGURE 26 PFIZER INC: SWOT ANALYSIS

FIGURE 27 FRESENIUS KABI USA, LLC: SWOT ANALYSIS

FIGURE 28 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS

FIGURE 29 MAXWELLIA LTD: SWOT ANALYSIS

FIGURE 30 AUROBINDO PHARMA USA: SWOT ANALYSIS

FIGURE 31 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 32 APOTEX INC.: SWOT ANALYSIS

FIGURE 33 FERRING PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 34 NORDIC PHARMA, INC: SWOT ANALYSIS

FIGURE 35 EXELA PHARMA SCIENCES LLC: SWOT ANALYSIS